Overview

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the conversion to monotherapy trial (SP902).

Phase:

Phase 3

Details

Lead Sponsor:

UCB Pharma

Treatments:

Lacosamide